Miako Sakaguchi

3PUBLICATIONS
9CO-AUTHORS
Major global burdens of diseaseMedical virologyBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 30, 2025
Development of a Novel, Highly Sensitive System for Evaluating Ebola Virus Particle Formation.

Wakako Furuyama, Miako Sakaguchi, Hanako Ariyoshi

|Jul 30, 2024
Marburg virus exploits the Rab11-mediated endocytic pathway in viral-particle production.

Wakako Furuyama, Kento Yamada, Miako Sakaguchi

|Oct 05, 2020
Novel Babesia bovis exported proteins that modify properties of infected red blood cells.

Hassan Hakimi, Thomas J Templeton, Miako Sakaguchi

Pageof 1

Frequent Collaborators

2 joint publications

Wakako Furuyama

2 joint publications

Asuka Nanbo

1 joint publications

Hassan Hakimi

1 joint publications

Kazuhide Yahata

1 joint publications

Takayuki Uchihashi

1 joint publications

Shin-Ichiro Kawazu

1 joint publications

Osamu Kaneko

1 joint publications

Masahito Asada

1 joint publications

Andrea Marzi

Frequent Collaborators

2 joint publications

Wakako Furuyama

2 joint publications

Asuka Nanbo

1 joint publications

Hassan Hakimi

1 joint publications

Kazuhide Yahata

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on : Sep 27, 2014

36.4K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

58.9K
Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers (Diethylaminoethyl-cellulose Columns)
14:26

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers (Diethylaminoethyl-cellulose Columns)

Published on : Apr 06, 2019

10.6K
See more related videos

Top Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on : Sep 27, 2014

36.4K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

58.9K
Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers (Diethylaminoethyl-cellulose Columns)
14:26

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers (Diethylaminoethyl-cellulose Columns)

Published on : Apr 06, 2019

10.6K
See more related videos